Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis? Ana Martins, Sofia Pimenta, Daniela Oliveira, Rafaela Nicolau, Alexandra Bernardo, Teresa Martins Rocha, Lúcia Costa, Miguel Bernardes

Is Palindromic Rheumatism a Pre-rheumatoid Arthritis Condition? Low Incidence of Rheumatoid Arthritis in Palindromic Rheumatism Patients Treated with Tight Control Strategy Alireza Khabbazi, Mohammad Mirza-Aghazadeh-Attari, Mohammad Tagi Goli, Aida Malek Mahdavi, Mehrzad Hajialilo, Nadereh Rashtchizadeh

Patient-reported outcomes in RA patients treated with tofacitinib or bDMARDs in real-life conditions in two Latin American countries J.M. Reyes, M.V. Gutierrez, H. Madariaga, W. Otero, R. Guzman, J. Izquierdo, M. Abello, P. Velez, D. Castillo, D. Ponce de Leon, T. Lukic, L. Amador